NewAmsterdam Pharma Company N.V. Ordinary Shares Cash Flow Reinvestment Rate

Latest as of December 2022: 0.00x

NewAmsterdam Pharma Company N.V. Ordinary Shares cash flow reinvestment rate. NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting $109.43K (capex $109.43K ) from operating cash flow of $29.19 Million. Explore NewAmsterdam Pharma Company N.V. Ordinar cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$109.43K
Capex + Investments

Operating Cash Flow

$29.19 Million
USD

Capital Expenditures

$109.43K
USD

Cash Flow Reinvestment Rate of NewAmsterdam Pharma Company N.V. Ordinary Shares (2022–2022)

Cash flow reinvestment rate of NewAmsterdam Pharma Company N.V. Ordinary Shares from 2022 to 2022. Historical reinvestment intensity for NewAmsterdam Pharma Company N.V. Ordinary Shares across 1 annual periods. Explore NewAmsterdam Pharma Company N.V. Ordinar capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

NewAmsterdam Pharma Company N.V. Ordinary Shares Cash Flow Reinvestment Rate by Year (2022–2022)

NewAmsterdam Pharma Company N.V. Ordinary Shares cash flow reinvestment rate by year from 2022 to 2022. Year-by-year capital reinvestment analysis for NewAmsterdam Pharma Company N.V. Ordinary Shares. For the full cash flow conversion analysis, see cash efficiency ratio of NewAmsterdam Pharma Company N.V. Ordinar.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2022 0.09x $936.00K $10.66 Million $221.00K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow